The Future of Alzheimer’s Prevention
Atria.org / Health Education / The Future of Alzheimer’s Prevention
Dr. Richard Isaacson is transforming the way we think about Alzheimer’s prevention. A trailblazer in the field, he shares how genetic insights and personalized strategies are reshaping early intervention—offering hope where there once was uncertainty.
About the episode
In this episode of Atria’s Vanguard Symposia, pioneering neurologist Dr. Richard Isaacson discusses the future of Alzheimer's prevention, highlighting his cutting-edge research and the crucial role of personalized medicine. Dr. Isaacson explains how researchers can now use genetic data and risk factors to design individualized care plans, benefiting high-risk individuals earlier. He takes listeners through the ways that genetic predispositions inform prevention strategies and outlines evidence-based interventions that are being used to develop a robust preventive framework. The conversation covers emerging technologies like digital health tracking, cognitive monitoring, and non-invasive diagnostic testing, which are bringing us into a new era of Alzheimer's prevention.
About the series
Atria’s Vanguard Symposia is a lecture series where some of the world’s most compelling researchers translate leading-edge science into medicine. In each episode, top experts share breakthrough science about preventive health care, dive deep into headline-grabbing topics, and take you beyond the buzzwords to explain the latest in longevity science. Our show will arm you with practical information and the tools of discernment to cut through the hype and understand what matters most.
Atria Health and Research Institute aims to accelerate a global shift from reactive sick care to proactive, preventive health care. We work at the forefront of science and technology and we believe a collaborative approach to modern medicine can extend healthy life for all.
Read more
Peptides for Longevity
Article
Longevity
Brain health
Peptides have become one of the most talked-about topics in longevity circles, with claims ranging from anti-aging breakthroughs to rapid recovery from age-related conditions. These short chains of amino acids do possess legitimate biological activity—several peptides serve as medications approved by the United States Food and Drug Administration (FDA) for specific conditions—but there is a vast gap between sanctioned medical uses and the sweeping wellness claims online.
The Science of Cryotherapy
Article
Performance & movement
Brain health
Metabolic health
Mind body
Whole-body cryotherapy involves brief exposure to extremely cold air. Current evidence suggests it works through multiple physiological pathways—affecting blood vessels, immune function, antioxidant systems, and the nervous system—resulting in short-term reductions in inflammation, oxidative stress, and pain. Our experts explain what to know cryotherapy and how to stay safe if you consider trying it.
The Facts About Statins and Dementia Risk
Article
Longevity
Mind body
If you’ve spent any time on social media lately, you may have seen alarming posts claiming that statin medications can cause dementia or memory loss. These posts often spread widely, leaving people concerned. Our experts explain why a large body of scientific evidence shows the opposite is true.
Sorry no results match your query